Bio Path Holdings News

BPTHDelisted Stock  USD 0.19  0.01  5.00%   
Under 61% of Bio Path's investor base is looking to short. The analysis of overall sentiment of trading Bio Path Holdings otc stock suggests that many investors are alarmed at this time. Bio Path's investing sentiment shows overall attitude of investors towards Bio Path Holdings.
  
over three months ago at insidermonkey.com         
Bio-Path Holdings, Inc. Q3 2024 Earnings Call Transcript
insidermonkey News
over three months ago at globenewswire.com         
Bio-Path Holdings Reports Third Quarter 2024 Financial Results
Macroaxis News: globenewswire.com
over three months ago at seekingalpha.com         
Bio-Path GAAP EPS of -0.70
seekingalpha News
over three months ago at investing.com         
Earnings call Bio-Path Holdings reports Q3 2024 financials, pipeline updates
Investing News at Macroaxis
over three months ago at seekingalpha.com         
Bio-Path Q3 2024 Earnings Preview
seekingalpha News
over three months ago at thelincolnianonline.com         
Short Interest in Bio-Path Holdings, Inc. Drops By 80.0
news
over three months ago at www.macroaxis.com         
Acquisition by Garrison Thomas E of 400000 shares of Bio Path at 1.5 subject to Rule 16b-3
Macroaxis News
over three months ago at thelincolnianonline.com         
Bio-Path to Release Earnings on Friday
news
over three months ago at finance.yahoo.com         
Bio-Path Holdings to Announce Third Quarter 2024 Financial Results on November 15, 2024
Yahoo News
over three months ago at gurufocus.com         
Hudson Bay Capital Management LP Acquires New Stake in Bio-Path Holdings Inc
Gurufocus Stories at Macroaxis
over three months ago at www.macroaxis.com         
Acquisition by Cleaver Heath of 2000 shares of Bio Path at 1.55 subject to Rule 16b-3
Macroaxis News
over three months ago at thelincolnianonline.com         
Bio-Path Research Coverage Started at StockNews.com
news
over three months ago at seekingalpha.com         
Bio-Path files to sell 17.76M shares of common stock for holders
seekingalpha News
over three months ago at thelincolnianonline.com         
Short Interest in Bio-Path Holdings, Inc. Drops By 41.5
news
over three months ago at finance.yahoo.com         
Bio-Path Holdings Announces Closing of 4.0 Million Private Placement Priced At-the-Market Under Nasd...
Yahoo News
Far too much social signal, news, headlines, and media speculation about Bio Path that are available to investors today. That information is available publicly through Bio media outlets and privately through word of mouth or via Bio internal channels. However, regardless of the origin, that massive amount of Bio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Bio Path news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Bio Path relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Bio Path's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Bio Path alpha.

Bio Path Performance against Dow Jones

 Price Growth (%)  
       Timeline  
Check out Bio Path Hype Analysis, Bio Path Correlation and Bio Path Performance.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Consideration for investing in Bio OTC Stock

If you are still planning to invest in Bio Path Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bio Path's history and understand the potential risks before investing.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Bonds Directory
Find actively traded corporate debentures issued by US companies